Publications

Peer-Reviewed Publications

Manuscripts

1.      Noh S, Nessim C, Keung EZ, Strauss D, Cananzi FCM, Chen J, Ford SJ, Rutkowski P, Pennacchioli E, Cardona K, Hompes D, Kollár A, Vassos N, Raut CP, Krakorova DA, Quildrian SD, Perhavec A, Nizri E, Farma JM, Vincenzi B, Lopez JAG, Iwata S, Kim T, Tolomeo F, Snow H, Tzanis D, Nikulin M, Gronchi A, and Sicklick JK. The Natural History of Ganglioneuroma: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg. 2022, Accepted in Press

2.      Bergeron A, Nessim C. SkIN Canada Priority Setting Initiative ranks the top 10 knowledge gaps in Merkel cell carcinoma research landscape, will be submitted

3.      Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg Collaborative. The impact of surgical delay on resectability of colorectal cancer:  An International Prospective Cohort Study. Colorectal Disease. DOI: 10.1111/codi.16117. (Impact Factor: 3.917)

4.      Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Pritchard-Jones R, Johansson I, Bagge RO, Wright LJ, Patel NG, Sondak V, Thompson JF, Zager JS. Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International Multicentre Study. Annals Surg Onc. https://doi.org/10.1245/s10434-022-11761-4. (Impact Factor: 3.857).

5.      Tirotta F, Napolitano A, Noh S, Schmitz E, Nessim C, Patel D, Sicklick JK, Smith M, Thway K, van der Hage J, Ford SJ, Tseng WW. Current Management of Benign Retroperitoneal Tumors. EJSO. https://doi.org/10.1016/j.ejso.2022.07.006 Accepted in Press

6.      Ivankovic V, Delisle M, Stacey D, Abou-Khalil J, Balaa F, Bertens KA, Dingley B, Martel G, McAlpine K, Nessim C, Tadros S, Carrier M, Auer RC. Beta testing of a risk-stratified patient decision aid to facilitate shared decision-making for post-operative extended thromboprophylaxis in patients undergoing major abdominal surgery for cancer (TPDA Study). Submitted to World Journal of Surgery

7.      Moncrieff MD, Lo SN, Scolyer RA, Heaton MJ, Nobes JP, Snelling AP, Carr MJ, Nessim C, Wade R, Peach AH, Kisyova R, Mason J, Wilson ED, Nolan G, Pritchard-Jones R, Johansson I, Bagge RO, Wright LJ, Patel NG, Sondak V, Thompson JF, Zager JS. Clinical Outcomes and Risk Stratification of Early-Stage Melanoma Micrometastases from the International MultiCenter Study: Implications for the Management of AJCC IIIA Disease.  JCO. DOI: http//doi.org/10.1200/ICO.21.02488. (Impact Factor: 32.956)

8.      Parvez E, Khorsrow-Khavar F, Dumitra T,  Nessim C , Rivard J, Wang S, Pravong V, Gervais M-K, Meterissian S, Dumitra S.  Real-life application of MSLT-II: Mulitcenter adoption and outcomes of nodal observation for patients with melanoma and sentinel lymph node metastases. Submitted to ASO

9.      Walker R, Look-Hong N, Moncreiff M, van Akkooi ACJ, Jost E, Nessim C, vanHoudt W, Stahlie EHA, Seo C, Quan ML, Mckinnon G, Wright F, Mavros MN. Predictors of sentinel lymph node metastasis in patients with thin melanoma: An international multi-institutional collaboration.  Annals Surg Onc. 2022. DOIhttps://doi.org/10.1245/s10434-022-11936-z. (Impact Factor: 3.857).

10.  Tseng WW, Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Ford SJ, Gonzalez RJ, Gladdy RA, Gyorki DE, Fairweather M, Won Lee K, Albertsmeier M, vanHoudt WJ, Fau M, Nessim C, Grignani G, Cardona K, Quagliuolo V, Grignol V, Farma JM, Pennacchioli E, Fiore M, Hayes A, Tzanis D, Skoczylas J, Almond ML, Mullinax JE, Burtenshaw S, Snow H, Haas RL, Callegaro D, Smith MJ, Bouhadiba T, Desai A, Voss R, Sanfilippo R, Jones RL, Baldini EH, Wagner AJ, Catton CN, Stacchiotti S, Thway K, Roland CL, Raut CP and Gronchi A on behalf of TARSWG. Management of Locally Recurrent Retroperitoneal Sarcoma in Adults: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Annals Surg Onc. 2022. https://doi.org/10.1245/s10434-022-11864-y. (Impact Factor: 3.857).

11.  Schmitz E, Nessim C. Retroperitoneal Sarcoma Care in 2021. Cancers 2022, 14(5), 1293; https://doi.org/10.3390/cancers14051293 (Impact Factor: 6.126).

12.  Corn S, Rolland C, Nessim C, Freeman C, Dumitra S. Data Dissemination of the Role of Neoadjuvant Radiation in Sarcoma: A CTOS and CSSO Survey. Submitted to European Journal of Surgical Oncology

13.  Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. The Lancet Oncology. 2021. https://doi.org/10.1016/S1470-2045(21)00493-9 (Impact Factor: 41.316) Citations: 2

14.  Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg Collaborative. Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. Br Journal of Surg  2021; 108: 1448-1464. (Impact Factor: 6.939)

15.  Frenda G, Baker L, Zhang Y, Nessim C. Use of a Skin Bridge Incision & Prophylactic Incisional Negative Pressure Wound Therapy Associated with Reduction in Surgical Site Infections Following Inguinal Lymph Node Dissection. Canadian Journal Surgery, In Press (Impact Factor: 2.544)

16.  Kupper S, Wright F, Dingley B, Nessim C, Quan ML. Extent of groin dissection in melanoma: a population-based study of practice patterns and outcomes. Current Oncology 2021, 28(6): 5422-5433. (Impact Factor: 3.677)

17.  Medor MC,  Ibrahim AM, Nessim C, Momtazi M. LYMPHA: Eliminating the Burden of Lymphedema in Cancer Patients Requiring Nodal Dissections Using Prophylactic Immediate Lymphatic Reconstruction – A Case Report and Review of the Literature. Plastic Surgery Case Studies. 2021 https://doi.org/10.1177/2513826X211028930.

18.  Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anesthesia, 2021: doi:10.1111/anae.15563 (Impact Factor: 6.955)

19.  Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg Collaborative. Machine Learning Risk Prediction of Mortality for patients undergoing surgery with peri-operative SARS-CoV-2: The COVID Surg Mortality Score. British Journal of Surgery, 2021: doi: 10.1093/bjs/znab183 (Impact Factor: 6.939)

20.  Gotfrit J, Goodwin R, Asmis T, Hyde AJ, Alcindor T, Aubin F, Berry S, Bossé D, Brown C, Burkes R, Burnell M, Champion P, Colwell B, Corbett J, Craswell J, Daaboul N, Di Valentin T, Doherty M, D.A.B. Fleming MD, L. Galvis MD, R. Goel MD, M. Harb MD, T. Hill MD, A. Jeyakuymar MD, D. Jonker Kennedy E, Lock M, Mahmud A, McCrea P, Nair V, Nassabein R, Nessim C, Ramjeesingh R, Raza M, Saliba W, Samimi S, Singh S, Snow S, Tehfé M, Thirlwell M, Valdes Salinas M, Welch S, and Vickers M. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019. Current Oncology 2021;28(3):1988-2006. doi: 10.3390/curroncol28030185. (Impact Factor: 3.677).

21.  Boulva K, Apte SS, Yu AM, Tran A, Shorr R, Song X, Ong M, Nessim C. Contemporary neoadjuvant therapies for high-risk melanoma: a systematic review. Cancers, 2021:13(8): 1905.doi: 1 0.3390/cancers13081905. (Impact Factor: 6.126). Citations: 2

22.  Zhou S, Sikorski D, Hao H, Chergui M, Miller WH, Spatz A, Redpath M, Ghazal S, Butler M, Petrella T, Claveau J, Nessim C, Salopek T, Gniadecki R and Litvinov I. Defining the criteria for reflex testing for BRAF mutations in cutaneous melanoma patients. Cancers, 2021: 13(9): 2282. doi: 10.3390/cancers13092282 (Impact Factor: 6.126). Citations: 2

23.  Apte SS, Radonjic A, Wong B, Dingley B, Boulva K, Purgina B, Chatterjee A, Ramsay T, Nessim C. Imaging versus pathologic size discrepancy of gastric GISTs. Implications for management: A retrospective cohort study. Journal of Surgical Oncology, 2021; doi: 10.1002/jso.26494 (Impact Factor: 3.244). Citations: 1

24.  Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Rutkowski P, Blay J-Y, Lahat G. Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, de Paoli A, Pillarisetty V, Swallow CJ, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fariweather M, Gronchi, Bagaria SP. An Analysis on Change in Differentiation at the time of first recurrence of Retropritoneal Liposarcoma by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Annals of Surgical Oncology, 2021:28(12): 7854-7863.  doi: 10.1245/s10434-021-10024-y. (Impact Factor: 3.857). (This article was used for the SSO: journal-based continuing medical education (CME)/Maintenance of Certification (MOC) program) Citations: 8

25.  Nessim C. (Collaborator– Ottawa Hospital Lead) COVID-Surg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from and international prospective cohort study. British Journal of Surgery 2021; doi: 10.1093/bjs/znab101. (Impact Factor: 5.899)

26.  Nessim C. (Collaborator– Ottawa Hospital Lead) COVID-Surg Collaborative. Timing of Surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia 2021; doi: 10.1111/anae.15458. (Impact Factor: 5.739)

27.  Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Grignani G, Hompes D, Ford S, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Gabriel E, Pennacchioli E, Albertsmeier M, Canter R, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Goel M, Patkar S, Gyorki D, Gangi A, Rastrelli M, Gelderblom H, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Postoperative pancreatic fistula following distal pancreatectomy for primary retroperitoneal sarcoma: an analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Annals of Surgical Oncology, 2021; doi: 10.1245/s10434-021-09739-9. (Impact Factor: 3.857). Citations: 3

28.  Milkovich J, Hanna T, Nessim C, Patrella TM, Weatherhead L, Chan A-W, Irish JC, Murray C, Bannerman G, Holloway C, Forster K, Pazzano L, Wright FC and the Ontario Skin Cancer Advisory Committee. Restructuring Skin Cancer Care in Ontario: A Provincial Plan. Current Oncology, 2021;28: 1183-1196. https://doi.org/10.3390/curroncol28020114. (Impact Factor: 3.677)

29.  Keller BA, Laight BJ, Varette O, Broom A, Wedge M-È, McSweeney B, Cemeus C, Petryk J, Lo B, Burns B, Nessim C, Ong M, Chica RA, Atkins HL, Diallo J-S, Ilkow CS,  Bell JC. Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation. Journal of Cancer Research and Clinical Oncology 2021; 147(5):1365-1378; doi: 10.1007/s00432-021-03545-2. (Impact Factor: 3.656). Citations: 2

30.  Swallow CJ, Strauss D, Bonvalot S, Rutkowski P, Desai A, Gladdy R, Gonzalez R, Gyorki DE, Fairweather M, van Houdt WJ, Stoeckle E, Park JB, Albertsmeier M, Nessim C, Cardona K, Fiore M, Hayes A, Tzanis D, Skoczylas J, Ford SJ, Ng D, Mullinax JE, Snow H, Haas RL, Callegaro D, Smith MJ, Bouhadiba T, Stachiotti S, Jones RL, DeLaney T, Roland CL, Raut CP, Gronchi A on behalf of the Trans-Atlantic Australasian RPS Working Group. Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group. Annals of Surgical Oncology, 2021; doi: 10.1245/s10434-021-09654-z. (Impact Factor: 3.857). Citations: 23

31.  Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Rutkowski P, Blay J-Y, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, de Paoli A, Pillarisetty V, Swallow CJ, Bagaria SP, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Fiore M, Fariweather M, Gronchi A, Lahat G. Postoperative Morbidity after Resection of Recurrent Retroperitoneal Sarcoma: A report from the Transatlantic Australasian RPS Working Group (TARPSWG). Annals of Surgical Oncology, 2021; doi: 10.1245/s10434-020-09445-y (Impact Factor: 3.857). Citations: 15

32.  Birdi HK, Jirovec A, Cortés-Kaplan S, Werier J, Nessim C, Diallo JS, Ardolino M. Immunotherapy for sarcomas: new frontiers and unveiled opportunities. Journal for Immunotherapy of Cancer, 2021;9(2):e001580. doi: 10.1136/jitc-2020-001580. (Impact Factor: 10.252). Citations: 9

33.  Wong B, Apte SS, Tirotta F, Parente A, Mathieu J, Ford SJ, Desai A, Almond M, Nessim C. Perioperative blood transfusion is not an independent predictor for worse outcomes in retroperitoneal sarcoma surgery. European Journal of Surgical Oncology, 2021; doi: 10.1016/j.ejso.2021.01.007 (Impact Factor: 3.480). Citations: 1

34.  Tattersall HL, Hodson J, Cardona K, Lee RM, Nessim C, Fiore M, Gladdy R, Gelderblom H, Schrage Y, Tseng W, vanHoudt W, Novak M, Grignani G, Tolomeo F, Goel N, Ryon E, Gyorki D, Bagaria SP, Gonzalez JA, Martin Arnau AB, Sayyed R, Tirotta F, Desai A, Almond M, Glasbey J, Gronchi A, Ford SJ.  Primary Mesenteric Sarcomas - A Collaborative experience by the Trans-Atlantic Australasian Retroperitoneal Sarcoma working group (TARPSWG). Journal of Surgical Oncology, 2021;123(4):1057-1066. doi: 10.1002/jso.26353. (Impact Factor: 3.244). Citations: 3

35.  Tseng WW, Barretta F, Conti L, Grignani G, Tolomeo F, Albertsmeier M, Angele MK, Rutkowski P, Skoczylas J, DePaoli A, Navarria F, Hu JS, Raut CP, Fairweather M, Farma JM, Nessim C. Goel N, Subhawong T, Grignol VP, Lee RM, Cardona K, Tattersall HL, Ford SJ, Gronchi A. Defining the Role of Neo-Adjuvant Systemic Therapy in High Risk Retroperitoneal Sarcoma: a Study by TARPSWG. Cancer, 2021;127(5):729-738. doi: 10.1002/cncr.33323. (Impact Factor: 5.742). Citations: 9

36.  Nessim C. (Collaborator – Ottawa Hospital Lead) COVID-Surg-Cancer Collaborative. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. British Journal of Surgery. 2021;108(1):88-96. doi: 10.1093/bjs/znaa051. (Impact Factor: 6.939). Citations: 1

37.  Nessim C. (Collaborator– Ottawa Hospital Lead) COVID-Surg-Cancer Collaborative. Elective Cancer Surgery in COVID-19 free surgical pathways during SARS-CoV-2 pandemic: An international, multi-centre, comparative cohort study. Journal of Clinical Oncology. 2021;39(1):66-78. doi: 10.1200/JCO.20.01933. (Impact Factor: 32.956)

38.  Li H, Bailey AJM, Grose E, McDonald JT, Quimby A, Johnson-Obaseki S, Nessim C. Socioeconomic status and melanoma in a universal healthcare system: A Sytematic Review.  Journal of Cutaneous Medicine & Surgery. 2021;25(1):87-94. doi: 10.1177/1203475420960426. (Impact Factor: 1.212). Citations: 1

39.  Nessim C. (Collaborator– Ottawa Hospital Lead) COVID-Surg-Cancer Collaborative. Outcomes of elective colorectal surgery during the SARS-CoV-2 pandemic. Colorectal Disease, 2020; doi: 10.1111/codi.15431(Impact Factor: 2.930)

40.  Nessim C. (Collaborator– Ottawa Hospital Lead) COVID-Surg-Cancer Collaborative. Delaying surgery for patients with a previous SARS‐CoV‐2 infection. Br Journal Surg. 2020;107(12):e601-e602. doi: 10.1002/bjs.12050. (Impact Factor: 6.939). Citations: 2

41.  van Houdt W, Fiore M, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Nessim C, Swallow CJ, Bagaria SP, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Callegaro D, Fairweather M, Miceli R, Raut CP, Gronchi A and RA Gladdy. Patterns of Recurrence and Survival Rates  following Second Relapse of Retroperitoneal Sarcoma: A study from TARPSWG. Cancer, 2020; 126(22):4917-4925. doi: 10.1002/cncr.33139. (Impact Factor: 5.742), Citations: 10

42.  Wright FC, Kellett S, Sun A, Hanna T, Nessim C, Look-Hong NJ, Giacomantonio CA, Temple-Oberle CF, Song X, Patrella TM. Locoregional Management of In-Transit Metastasis in Melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline. Current Oncology. 2020; 27(3): 318-325. (Impact Factor: 3.677). Citations: 5

43.  Ibrahim AM, Le May M, Bosse D, Marginean H, Song X, Nessim C and Ong M. Impact of Imaging Intensity and Survival Outcomes in High-Risk Resected Melanoma Treated by Systemic Therapy at Recurrence. Ann Surg Oncol. 2020, EPUB ahead of print on May 11, 2020 doi: 10.1245/s10434-020-08407-8. (An editorial was written about this article by authors from Memorial Sloan Kettering Cancer Center in NY,  in Annals of Surgical Oncology https://link.springer.com/article/10.1245/s10434-020-08633-0) (Impact Factor: 3.857). Citations : 8

44.  Monteiro-de-Barros J, Hodson J, Glasbey J, Massey R, Rintoul-Hoad O, Chetan M, Desai A, Almond M, Gourevitch D, Strauss D, Smith H, Cardona K, Lopez-Aguiar A, Johnson A, Swallow C, Burtenshaw S, Nessim C, Weng R, Purgina B, Gronchi A, Fiore M, Vallegro D, Raut C, Fairweather M, Bagaria S, Novak M, Gyorki D, Reid F, Mullinax J, Gonzalez R, van Coeverden F, van Houdt W, Haas R, van Boven H, Heeres B, Ford S. Intercontinental Collaborative experience with Abdominal, Retroperitoneal and Pelvic Schwannomas. British Journal of Surgery. 2020; 107(4):452-463. doi: 10.1002/bjs.11376. (Impact Factor: 6.939). Citations: 4

45.  Wright F, Souter LH, Kellett S, Easson A, Murray C, Toye J, McCready D, Nessim C, Ghazarian D, Look Hong N, Johnson S, Goldstein D, Petrella T. Primary Excision Margins, Sentinel Lymph Node Biopsy and Completion Dissection in cutaneous Melanoma.  Current Oncology. 2019; 26(4):e541-e550. doi: 10.3747/co.26.4885. (Impact Factor: 3.677). Citations: 19

46.  Pang G, Look Hong NJ, Paull G, Kupper S, Hurton S, Dobransky J, Kagedan DJ, Quan ML, Helyer L, Nessim C and Wright F. Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: An Analysis of Outcomes. Annals of Surgical Oncology. 2019;26(13):4642-4650. doi: 10.1245/s10434-019-07743-8. (Impact Factor: 3.857). Citations: 3

47.  Berger-Richardson D, Burtenshaw SM, Ibrahim AM, Gladdy RA, Auer R, Beecroft R, Dickson BC, Purgina B,  Ambacher K, Nessim C and Swallow CJ.  Early and late complications of percutaneous core needle biopsy of retroperitoneal tumors at two tertiary sarcoma centers. Ann Surg Oncol. 2019;26(13):4692-4698. doi: 10.1245/s10434-019-07656-6. (This article was used for the SSO: journal-based continuing medical education (CME)/Maintenance of Certification (MOC) program and an editorial was written about this article in Annals of Surgical Oncology by authors from Dana Farber Cancer Center, Harvard - https://link.springer.com/article/10.1245/s10434-019-07723-y) (Impact Factor: 3.857). Citations: 12 

48.  Gilbert RWD, Harvey HM,  Nessim C. Malignant Melanoma arising from an End Ileostomy. BMJ Case Reports, 2019. 12(7): pii: e230265. Doi: 10.1136/bcr-2019-230265.

49.  Raut CP, Callegaro D, Barretta F, Rutkowski P, Blay J-Y, Lahat G, Strauss DC, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, de Paoli A, Pillarisetty V, Nessim C, Swallow CJ, Bagaria S, Canter R, Mullen J, Gelderblom HJ, Pennacchioli E, van Coevorden F, Cardona K, Miceli R, Gronchi A. Predicting Survival in patients undergoing resection for locoregionally recurrent retroperitoneal sarcoma: A study and nomogram from the Trans-Atlantic Sarcoma Working Group (TARPSWG). Clinical Cancer Research. 2019; 25(8): 2664-2671. doi: 10.1158/1078-0432.CCR-18-2700. (Impact Factor: 10.107). Citations: 44

50.  Sulaiman A, McGarry S, Lam KM, El-Sahli S, Chambers J, Kaczmarek S, Li L, Addison C, Dimitroulakis J, Arnaout A, Nessim C, Yao Z, Ji G, Song H, Liu S, Li X, Wang L. Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells. Cell Death Disease. 2018; 9(8): 815. doi: 10.1038/s41419-018-0811-7. (Impact Factor: 5.910). Citations: 21

51.  Gawad N, Ibrahim A, Duffy M, Raiche I, Nessim C. Going beyond the numerical scoresheet: identifying narcissistic traits in residency applicants. Journal of Surgical Education. 2019; 76(1):65-76. doi:10.1016/j.jsurg.2018.06.024. (Impact Factor: 2.220). Citations: 1

52.  Hasim MS, Nessim C, Villeneuve PJ, Vanderhyden BC and Dimitroulakos J. Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer. Translational Oncology 2018: 11(4): 988-998. doi: 10.1016/j.tranon.2018.06.001. (Impact Factor: 3.558). Citations: 15

53.  Authors listed in alphabetical order Nessim C et al. Management of Metastatic Retroperitoneal Sarcoma (RPS) – A Consensus Approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Annals of Oncology 2018; 29(4): 857-871. doi: 10.1093/annonc/mdy052. (Impact Factor: 18.274). Citations: 21

54.  Sulaiman A, McGarry S, Li L, Jia D, Oi S, Addison C, Dimitroulakis J, Arnaout A, Nessim C, Yao Z, Ji G, Gadde S, Li X, Wang L.  Dual inhibition of Wnt and YAP signaling retards the growth of both mesenchymal and epithelial TNBC. Molecular oncology 2018; 12(4): 423-440. doi:10.1002/1878-0261.12167. (Impact Factor: 6.574). Citations: 38

55.  Crawford, Nessim C, Weaver J, van Walraven C. Wait times for melanoma surgery: Is there an association with overall survival? Annals of Surgical Oncology 2017; 25(1): 265-270. doi. 10.1245/s10434-017-6146-2. (Impact Factor: 3.857). Citations: 13

56.  Zhang Y, Cordeiro E, Seely J, Hefler J, Gravel D, Smylie J, Aro J, Nessim C. Radioactive Seed Localization vs. Wire-Guided Localization for non-palpable breast cancer: A Cost and OR efficiency analysis. Annals of Surgical Oncology 2017; 24(12): 3567-3573. doi. 10.1245/s10434-017-6084-z. (Impact Factor: 3.857). Citations: 36

57.  Ambacher K, Ibrahim A, Nessim C.  Ensuring a Safe and Qualitative Diagnostic Biopsy for Retroperitoneal Sarcomas. University of Ottawa Journal of Medicine 2017; 7(1): 45-48.

58.  Lim R, Kielar AZ, El-Maraghi RH, Fraser MA, Nessim C and Thipphavong S. Multidisciplinary Retroperitoneal and Pelvic Soft Tissue Sarcoma Case Conferences: The Added Value Radiologists Can Provide. Current Oncology 2017; 24(3): 171-175. DOI: https://doi.org/10.3747/co.24.3478. (Impact Factor: 3.677). Citations : 1

59.  Head L, Nessim C, Boyd KU. Innovative model to optimize resource utilization and improve access to care for high-risk/BRCA+ breast cancer patients. Canadian Journal of Surgery 2017; 60(1): 37-44. (Impact Factor: 2.544). Citations: 1

60.  Sulaiman A, Sulaiman B, Khouri L, McGarry S, Nessim C, Arnaout A, Addison CL, Dimitroulakos J, Wang L. Both bulk and cancer stem cell subpopulations in TNBC are susceptible to Wnt, HDAC and ERα co-inhibition. FEBS Letters. 2016; 590(24): 4606-4616. doi: 10.1002/1873-3468.12496. (Impact Factor: 3.057). Citations: 24

61.  Authors listed in alphabetical order Nessim C et al. Management of Recurrent Retroperitoneal Sarcoma (RPS) – A Consensus Approach from the Trans-Atlantic RPS Working Group. Annals of Surgical Oncology 2016; 23(11): 3531-3540. doi: 10.1245/s10434-016-5336-7. (Impact Factor: 3.857). Citations: 63

62.  Tsvetkova E, Marginean C with Nessim C and Verma S. Gastrointestinal Stromal Tumor (GIST) – Paving the Way for Modern Oncology – Epidemiology, Diagnosis, Treatment.  Oncology and Hematology Review 2015; 11(1): 74–86 DOI: http://doi.org/10.17925/OHR.2015.11.01.74

63.  Nessim C, Winocour J, Holloway DP, Saskin R, Holloway CM. Wait times for breast cancer surgery: effect of magnetic resonance imaging and preoperative investigations on the diagnostic pathway. Journal of Oncology Practice. 2015; 11(2): e131-8. doi: 10.1200/JOP.2014.002105. (Impact Factor: 2.420). Citations: 13

64.  Nessim C, Law C, McConnell Y, Shachar S, McKinnon G, Wright F. How often do Level III nodes bear melanoma metastases and does it affect patient outcomes? Annals of Surgical Oncology 2013; 20(6): 2056-64. doi: 10.1245/s10434-013-2880-2. (Impact Factor: 3.857). Citations: 15

65.  Nessim C, Sidéris L, Turcotte S, Vafiadis P, Lapostole AC, Simard S, Koch P, Fortier LP, Dubé P.  The effect of fluid overload in the presence of an epidural on the strength of colonic anastomoses. Journal of Surgical Research 2013; 183(2): 567-79. doi: 10.1016/j.jss.2013.03.030. (Impact Factor: 2.187). Citations: 18

66.  Nessim C, Bensimon C, Hales B, Laflamme C, Fenech D, Smith A. Surgical Site Infection Prevention: A qualitative analysis on an individualized audit and feedback model. Journal of American College of Surgeons 2012; 215(6): 850-7. doi: 10.1016/j.jamcollsurg.2012.08.007. (Impact Factor: 5.122). Citations: 12

Editorials

1.      Delisle M, Bonvalot S, Gyorki DE, Nessim C. Landmark Series: A review of landmark studies in Primary Retroperitoneal Sarcoma. Submitted to ASO

2.      Lahat G, Raut CP, Gronchi A, Nessim C. ASO Reflections: Selecting patients for recurrent Retroperitoneal Sarcoma Surgery – The challenging trade-off between oncologic outcome and morbidity. Annals of Surgical Oncology, 2021; (Suppl 3):852-853. doi: 10.1245/s10434-021-10067-1. (Impact Factor: 3.857)

3.      Nessim C, Tzanis D. Is it time for a change in the model of care for AYA patients with Soft Tissue Sarcoma? How to improve outcomes for patients aged 15-25 using a mixed Pediatric-Adult Cancer Care Model in Expert Sarcoma Centers. European Journal Surgical Oncology. 2020; 46(7): 1201-1202. (Impact Factor: 3.480)

4.      Nessim C.  When is Watchful Waiting Warranted? Advances in Soft Tissue Sarcoma: an editorial commentary.  Annals of Surgical Oncology. 2019; 26(11):3420-3422. (Impact Factor: 3.857). Citations: 1

5.      Nessim C, Crawford A. ASO Reflections: Wait times in Melanoma Surgery. Annals of Surgical Oncology. 2018;  doi: 10.1245/s10434-018-7022-4. (Impact Factor: 3.857)

Book Chapters and Invited Articles

1.      Schmitz E, Dingley B, Nessim C. Virtual Malignant Bowel Obstruction Case for CAGS members on Website to obtain Section 3 credits

2.      Nessim C, Dumitra S, Fleiszer D, Posel N. Virtual Melanoma Case for CAGS members on Website to obtain Section 3 credits

3.      Apte SS, Nessim C. - Brief Specialty Updates for the General Surgeon – Clinical Practice Committee. Melanoma Surgery Literature Update: Edition 1.

4.      Nessim C. et al The Landmark Series: Clinical Trials in Retroperitoneal Sarcoma. Annals of Surgical Oncology. In Progress

5.      Nessim C. Society of Surgical Oncology Education SCORE module for Surgical Oncology Fellows on the Guidelines for the use of Sentinel Lymph node biopsy in melanoma, SSO 2018

6.      Nessim C, Ferguson P, Gupta A, Catton C, Gladdy R. Retroperitoneal and Extremity Soft Tissue Sarcoma. Chapter in the Toronto Surgical Oncology Manual, 1st edition, published by Springer International Publishing, New York, USA, April 2012.

7.      Nessim C, Govidarajan A, McCart A. Peritoneal Malignancies. Chapter in the Toronto Surgical Oncology Manual, 1st edition, published by Springer International Publishing, New York, USA, April 2012.

8.      Nessim C, Rotstein L, Goldstein D, Sun A, Hogg D, McCready D, Ghazarian D. Princess Margaret Hospital: Melanoma Guidelines, PMH website, June 2012.